Literature DB >> 1721264

A whole blood FK 506 assay for the IMx analyzer.

F C Grenier1, J Luczkiw, M Bergmann, S Lunetta, M Morrison, D Blonski, K Shoemaker, M Kobayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721264

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  22 in total

Review 1.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  FK506 measurement: comparison of different analytical methods.

Authors:  V Warty; S Zuckerman; R Venkataramanan; J Lever; J Fung; T Starzl
Journal:  Ther Drug Monit       Date:  1993-06       Impact factor: 3.681

3.  Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.

Authors:  Marie Antignac; Jean Sebastien Hulot; Emmanuel Boleslawski; Laurent Hannoun; Yvan Touitou; Robert Farinotti; Philippe Lechat; Saïk Urien
Journal:  Eur J Clin Pharmacol       Date:  2005-07-01       Impact factor: 2.953

4.  Pregnancy after liver transplantation under tacrolimus.

Authors:  A Jain; R Venkataramanan; J J Fung; J C Gartner; J Lever; V Balan; V Warty; T E Starzl
Journal:  Transplantation       Date:  1997-08-27       Impact factor: 4.939

5.  Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients.

Authors:  Marie Antignac; Christine Fernandez; Benoît Barrou; Mariona Roca; Jean-Louis Favrat; Saïk Urien; Robert Farinotti
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-02-24       Impact factor: 2.441

Review 6.  A risk-benefit assessment of tacrolimus in transplantation.

Authors:  M Winkler; U Christians
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

7.  Tacrolimus analysis: a comparison of different methods and matrices.

Authors:  V Warty; S Zuckerman; R Venkataramanan; J Lever; J Chao; T Mckaveney; J Fung; T Starzl
Journal:  Ther Drug Monit       Date:  1995-04       Impact factor: 3.681

8.  Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats.

Authors:  Y Hashimoto; H Sasa; M Shimomura; K Inui
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

Review 9.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.